Skip to main content
SpringerLink
Log in

Natural remedies in Scandinavia—authorization and sales

  • Original Paper
  • Published:
Pharmacy World & Science Aims and scope Submit manuscript

Abstract

Objective of the study

to quantify sales of authorized natural remedies (ANRs) in Norway, to compare the Norwegian authorization scheme with similar schemes in Sweden, Denmark and the EU, and to identify factors influencing the number of marketed ANRs.

Method

descriptive statistics are used to present sales of ANRs in Norway. The ANRs are classified by indication group and assigned a recommended daily dose (RDD) according to the posology section in the Summary of Product Characteristics (SPC). Document analysis of regulation and general information concerning natural remedies is used to compare the authorization schemes for ANRs in Scandinavia and for traditional herbal medicinal products (THMs) in the EU. Four cases of herbs are described to illustrate the consequences of this regulation and identify possible influencing factors.

Main outcome measure

sales, in terms of both mean consumer prices and number of RDDs, and the factors found to influence the number of marketed ANRs.

Results

total sales of ANRs in Norway in 2003 were € 1.5 per capita (3% of the food supplement market), or 5.5 RDD/1,000/day, and the sales have tended to decline. Norway has very few ANRs compared with Sweden and Denmark. Changes in Norwegian ANR regulation in 2004 have harmonized application requirements in Scandinavia, but results have yet to be seen. THMs are subject to the same quality requirements as ANRs, and will replace the ANRs over the next 7 years. Several factors have influenced the manufacturers’ application incentive, e.g., application costs, differentiated VAT rates, consumer knowledge and surveillance by health authorities.

Conclusion

sales of authorized compared to unauthorized natural remedies in Norway are very low and the ANRs are in a weak position compared to Denmark and Sweden. Surveillance by health authorities and increased consumer knowledge of ANRs is probably more stimulating with respect to application incentive than lower application costs. Introducing THMs will hopefully increase the number of quality-controlled products on the Scandinavian market.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Retningslinjer for godkjenning av naturlegemidler [Guidelines on authorization of natural remedies] Oslo: Norwegian Medicines Agency; 1998

  2. Helboe P, Bager S. Vejledning om markedsføringstilladelse til naturlægemidler [Guidelines on authorization of herbal medicinal products]. Copenhagen: Danish Medicines Agency; 2001

  3. Strandberg K, Sjøberg B. Guidelines on authorization to place natural remedies on the market. Stockholm: Medical Products Agency, LVFS; 1995:1101–5225

  4. Proposition No.55 to the Odelsting (2001–2002) concerning changes in the Act relating to medicines etc. and the Act relating to medicinal equipment. Oslo, Ministry of Health and Care Services; 2002 [in Norwegian]

  5. Directive 2004/24/EC of the European Parliament and of the Council of 31 March 2004 amending as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official J Eur Union. 2004;47(L 136):85–90

    Google Scholar 

  6. De Smet PAGM. Health risks of herbal remedies: an update. Clin Pharmacol Ther 2004;76(1):1–17

    Article  Google Scholar 

  7. Hanssen B, Grimsgaard S, Launsø L, Fønnebø V, Falkenberg T, Rasmussen NK. Use of complementary and alternative medicine in the Scandinavian countries. Scand J Prim Health Care 2005;23(1):57–62

    Article  PubMed  Google Scholar 

  8. Euro foreign exchange reference rates. The European Central Bank [homepage on the Internet] 2005 [cited 15.03.05]; Available from: http://www.ecb.int/stats/exchange/eurofxref/html/index.en.html

  9. Guidelines for ATC classification and DDD assignment. 6 ed. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 2003.ISBN 82–8082025–6

  10. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Commumity code relating to medicinal products for human use. Official J Eur Union. 2001;44(L 311):67–127

    Google Scholar 

  11. Fines J. Reading historical documents: a manual for students. Oxford: Basil Blackwell Limited; 1988. ISBN 0-631-90167-1

  12. Färnlöf Å, Mattsson KR. Marknadsfakta–om hälsokost, naturläkemedel, vitaminer, mineraler och naturkosmetik [Marketing figures–health food, authorized natural remedies, vitamins, minerals and natural cosmetics] The Health Food Council [homepage on the Internet] 2005 [cited 20.05.05]; Available from: http://www.halsokostradet.se/default.aspx?SelSidId=10006

  13. European Commission–Enterprise Directorate-General–Pharmaceuticals Unit. The Rules Governing Medicinal Products in the European Union Volum 2-Pharmaceutical Legislation: Notice to Applicants. Eudralex [homepage on the Internet] 2005 [cited 15.06.05]; Available from: http://www.pharmacos.eudra.org/F2/eudralex/vol-2/home.htm

  14. Forskrift om legemidler [Regulation regarding medicines] FOR 1999–12–22 Nr 1559

  15. Syse-utvalget [Report from the syse-committee]. Oslo: Ministry of Health and Care Services; 2003

    Google Scholar 

  16. Wesenberg GR. Generell dispensasjon fra Legemiddellovens § 20 [General dispensation from The Act relating to medicines, article 20]. Norwegian Medicines Agency: Circular letter No 10. 2001

  17. Madsen KH. Stigende problemer med markedsføringen af sundhedsprodukter [Increasing problems with the marketing of health food products] Danish Medicines Agency [press release] 9 May. 2005

  18. Dragland S. Rosenrot,-botanikk, innholdsstoff, dyrkning og bruk, en litteraturoversikt. [Arctic root,-botany, contents, cultivation and use, a literature review] vol 09. Planteforsk Grønn forskning. 2001;09 p 29

  19. Nilsen MG. Kunnskap og rådgivning om urtemedisin til gravide og ammende blant farmasøyter, leger og helsekostpersonale. [Knowledge and counselling regarding herbal medicine to pregnant and breastfeeding women, among pharmacists, physicians and health shop personnel] [Master’s thesis]. Oslo: University of Oslo; 2003

Download references

Acknowledgements

We wish to thank the Norwegian wholesalers of authorized natural remedies and Farmastat AS for providing sales data. We are also grateful for the information provided by NoMA, MPA and DKMA. The article is based on a Master’s thesis completed at the Institute of Pharmacy, University of Tromsø, Norway, in 2004. A grant was received from The Norwegian Pharmaceutical Society.

Author information

Authors and Affiliations

  1. Institute of Community Medicine, University of Tromsø, NO-9037, Tromsø, Norway

    Marit Waaseth & Anne Elise Eggen

  2. Clinical Research Center, University Hospital of North Norway, NO-9038, Tromsø, Norway

    Sameline Grimsgaard

Authors
  1. Marit Waaseth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne Elise Eggen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sameline Grimsgaard
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marit Waaseth.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Waaseth, M., Eggen, A. & Grimsgaard, S. Natural remedies in Scandinavia—authorization and sales. Pharm World Sci 29, 137–145 (2007). https://doi.org/10.1007/s11096-006-9033-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11096-006-9033-7

Keywords

Search

Navigation